Page last updated: 2024-09-03

modipafant and cp 105696

modipafant has been researched along with cp 105696 in 1 studies

Compound Research Comparison

Studies
(modipafant)
Trials
(modipafant)
Recent Studies (post-2010)
(modipafant)
Studies
(cp 105696)
Trials
(cp 105696)
Recent Studies (post-2010) (cp 105696)
29333316

Protein Interaction Comparison

ProteinTaxonomymodipafant (IC50)cp 105696 (IC50)
Leukotriene B4 receptor 1Homo sapiens (human)0.1131
Leukotriene B4 receptor 2Homo sapiens (human)0.2192
Cysteinyl leukotriene receptor 2Homo sapiens (human)0.0084
Cysteinyl leukotriene receptor 1Homo sapiens (human)0.0084

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BĂ©langer, C; Borgeat, P; Elimam, H; Lefebvre, J; Marleau, S1

Other Studies

1 other study(ies) available for modipafant and cp 105696

ArticleYear
Involvement of endogenous leukotriene B4 and platelet-activating factor in polymorphonuclear leucocyte recruitment to dermal inflammatory sites in rats.
    Immunology, 2008, Volume: 124, Issue:3

    Topics: Animals; Benzopyrans; Carboxylic Acids; Dermatitis; Dihydropyridines; Imidazoles; Leukotriene B4; Male; Neutrophil Infiltration; Neutrophils; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pneumonia; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Receptors, Leukotriene B4; Skin; Thiazoles

2008